Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2.
Jabbar TK, Calvo-Pinilla E, Mateos F, Gubbins S, Bin-Tarif A, Bachanek-Bankowska K, Alpar O, Ortego J, Takamatsu HH, Mertens PP, Castillo-Olivares J. Jabbar TK, et al. PLoS One. 2013 Apr 12;8(4):e60574. doi: 10.1371/journal.pone.0060574. Print 2013. PLoS One. 2013. PMID: 23593251 Free PMC article.
Recombinant vaccines against bluetongue virus.
Calvo-Pinilla E, Castillo-Olivares J, Jabbar T, Ortego J, de la Poza F, Marín-López A. Calvo-Pinilla E, et al. Virus Res. 2014 Mar;182:78-86. doi: 10.1016/j.virusres.2013.11.013. Epub 2013 Nov 25. Virus Res. 2014. PMID: 24287057 Review.
Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation.
Calvo-Pinilla E, de la Poza F, Gubbins S, Mertens PP, Ortego J, Castillo-Olivares J. Calvo-Pinilla E, et al. Virus Res. 2014 Feb 13;180:23-30. doi: 10.1016/j.virusres.2013.12.002. Epub 2013 Dec 12. Virus Res. 2014. PMID: 24333835
28 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page